S2C5：Oncology Clinical Trials

2020年2月18日 12:25 • 药时代知识宝库, 视频课, 音频课

原文始发于微信公众号（化学音乐文化）：S2C5：Oncology Clinical Trials

JanFourman,PhD, EdD,MBA, MSRA

S2C5：Oncology Clinical Trials

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years

Eli Lilly – Pharmacovigilance – 7 years

Eli Lilly – Regulatory Intelligence – 3 Years

Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US

Consultant for Indiana Technical Assistance Program

Invited conference speaker

Published author

扫描左侧二维码，获取视频课；扫描右侧二维码，获取音频课

Oncology Clinical Trials

The Oncology Initiative

FDAMA

Individual “Patient Access” to Investigational Drugs

Treatment IND

Development Strategies

Expanded Access

发布者：药时代，转载请首先联系contact@drugtimes.cn获得授权

打赏

为好文打赏支持药时代共创新未来！

上一篇 2020年2月18日 12:21

下一篇 2020年2月18日 12:29

返回顶部